ArticleInternational journal of clinical practice2021

Anosmia and dysgeusia amongst COVID-19 patients are associated with low levels of serum glucagon-like peptide 1.

Eli Ben-Chetrit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.